Stock RSH RESPIRI LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Respiri Limited

Equities

RSH

AU000000RSH4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 07:10:12 03/05/2024 BST 		5-day change 1st Jan Change
0.034 AUD +13.33% Intraday chart for Respiri Limited 0.00% +13.33%
04-30 Respiri to Raise AU$1.6 Million via Placement MT
04-29 Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3% MT

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 45.92 46.28 58 48.43 41.9 32.11
Enterprise Value (EV) 1 43.48 46.77 55.29 40.56 40.73 32.09
P/E ratio -13.3 x -5.18 x -6.99 x -4.24 x -6.04 x -5.28 x
Yield - - - - - -
Capitalization / Revenue 53.3 x 45.1 x 26.9 x 34.9 x 54.3 x 48.8 x
EV / Revenue 50.5 x 45.6 x 25.7 x 29.3 x 52.7 x 48.8 x
EV / EBITDA -14 x -5.52 x -7.57 x -3.66 x -6.16 x -5.58 x
EV / FCF -48 x -14.3 x -34.2 x -12.2 x -6.96 x -15.3 x
FCF Yield -2.08% -6.99% -2.92% -8.18% -14.4% -6.53%
Price to Book 27.8 x -29.6 x 23.2 x 6.4 x 13.9 x 38.8 x
Nbr of stocks (in thousands) 473,383 525,883 651,715 722,841 761,846 845,086
Reference price 2 0.0970 0.0880 0.0890 0.0670 0.0550 0.0380
Announcement Date 31/08/18 17/09/19 29/09/20 27/08/21 31/08/22 31/08/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.8615 1.026 2.155 1.386 0.7722 0.6579
EBITDA 1 -3.099 -8.475 -7.307 -11.08 -6.616 -5.752
EBIT 1 -3.225 -8.48 -7.313 -11.09 -6.631 -5.765
Operating Margin -374.35% -826.28% -339.28% -800.27% -858.74% -876.25%
Earnings before Tax (EBT) 1 -3.207 -8.475 -7.261 -11.04 -6.624 -5.775
Net income 1 -3.207 -8.475 -7.261 -11.04 -6.624 -5.775
Net margin -372.3% -825.78% -336.89% -796.56% -857.85% -877.89%
EPS 2 -0.007300 -0.0170 -0.0127 -0.0158 -0.009100 -0.007199
Free Cash Flow 1 -0.9054 -3.271 -1.616 -3.317 -5.852 -2.096
FCF margin -105.1% -318.71% -74.96% -239.29% -757.83% -318.62%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 31/08/18 17/09/19 29/09/20 27/08/21 31/08/22 31/08/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.49 - - - -
Net Cash position 1 2.43 - 2.71 7.87 1.18 0.03
Leverage (Debt/EBITDA) - -0.0575 x - - - -
Free Cash Flow 1 -0.91 -3.27 -1.62 -3.32 -5.85 -2.1
ROE (net income / shareholders' equity) -186% -19,237% -1,558% -219% -125% -301%
ROA (Net income/ Total Assets) -76% -288% -162% -101% -62.3% -97.5%
Assets 1 4.219 2.938 4.474 10.93 10.64 5.92
Book Value Per Share 2 0 -0 0 0.0100 0 0
Cash Flow per Share 2 0.0100 0 0.0100 0.0100 0 0
Capex 1 0.01 0 0.01 0.05 0 0.02
Capex / Sales 0.92% 0.31% 0.6% 3.91% 0.29% 3.31%
Announcement Date 31/08/18 17/09/19 29/09/20 27/08/21 31/08/22 31/08/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
RESPIRI LIMITED Stock Respiri Limited
+13.33% 23.83M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.84% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.35% 184B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.04% 135B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 62.38B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.80% 51.37B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.9B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.30% 40.87B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.78% 36.28B
RESMED, INC. Stock ResMed, Inc.
+26.14% 31.88B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. RSH Stock
  4. Financials Respiri Limited